Immunology

Researchers shorten manufacturing time for CAR T cell therapy

A new approach from Penn Medicine researchers could cut the time it takes to alter patients' immune cells for infusion back into the body to find and attack cancer. The cell manufacturing process for this type of immunotherapy ...

Medical research

Uncovering the HIV life cycle

Though it has been eclipsed lately by SARS-CoV-2, there is another global epidemic still threatening people: HIV/AIDS. According to UNAIDS, a United Nations initiative, some 38 million people worldwide are currently infected ...

Medical research

Are we any closer to an HIV vaccine?

While scientists have made unprecedented progress in preventing COVID-19 in the past two years, they have also moved closer to finding a vaccine to protect against the human immunodeficiency virus (HIV), which has been infecting ...

Diseases, Conditions, Syndromes

How will COVID end? Experts look to past epidemics for clues

Two years into the COVID-19 pandemic, most of the world has seen a dramatic improvement in infections, hospitalizations and death rates in recent weeks, signaling the crisis appears to be winding down. But how will it end? ...

HIV & AIDS

Experimental mRNA vaccine for HIV shows promise in animals

An experimental HIV vaccine based on mRNA—the same technology used in two highly successful COVID-19 vaccines—has shown promise in experiments in mice and monkeys, according to a study published Thursday in Nature Medicine.

page 7 from 40